|
Art. 62b Cooperation with the private sector 152
1 The Agency and the Federal Office for Customs and Border Security (FOCBS), after weighing up the interests, are entitled on a case-by-case basis to disclose confidential data collected in accordance with this Act to the holder of an operating licence or of a marketing authorisation for medicinal products or to any person who places a medical device on the market, including sensitive personal data in accordance with Article 5 letter c number 5 of the Data Protection Act of 25 September 2020153, provided this measure is regarded as necessary in order to uncover or combat suspected illegal trading in therapeutic products.154 2 Personal data relating to patients may not be disclosed. 152 Inserted by Annex No 2 of the FD of 29 Sept. 2017 (Medicrime Convention), in force since 1 Jan. 2019 (AS 2018 4771; BBl 2017 3135). 154 Amended by Annex 1 No II 74 of the Data Protection Act of 25 Sept. 2020, in force since 1 Sept. 2023 (AS 2022 491; BBl 2017 6941). |